Max W. Sung
Impact in
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
- Hepatology 48
- Hepatocellular Carcinoma Treatment and Prognosis 48
- Oncology 51
- Cancer Immunotherapy and Biomarkers 18
- Pancreatic and Hepatic Oncology Research 15
- Colorectal Cancer Treatments and Studies 9
- Lung Cancer Research Studies 9
- Co-authors
- Myron SchwartzJonathan D. SchwartzCharles M. MillerSukru EmreSasan RoayaieShu‐Hsia ChenJohnny KaoJohn Mandeli
- Journals
- Journal of Clinical Oncology (21 papers)Annals of Oncology (5 papers)Cancer (4 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Liver Cancer (2 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Max W. Sung
80 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Hepatology 2.2k
- Oncology 1.6k
- Pathology and Forensic Medicine 606
- Cancer Research 503
- Immunology 653
Countries citing papers authored by Max W. Sung
This map shows the geographic impact of Max W. Sung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max W. Sung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max W. Sung more than expected).
Fields of papers citing papers by Max W. Sung
This network shows the impact of papers produced by Max W. Sung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max W. Sung. The network helps show where Max W. Sung may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Max W. Sung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 8 | |
| 4 | 2023 | 1 | |
| 5 | 2021 | 10 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 8 | |
| 8 | 2020 | 99 | |
| 9 | 2020 | 82 | |
| 10 | 2020 | 9 | |
| 11 | 2020 | 7 | |
| 12 | 2020 | 30 | |
| 13 | 2018 | 1 | |
| 14 | 2017 | 17 | |
| 15 | 2015 | 90 | |
| 16 | 2013 | 69 | |
| 17 | Long-Term Results With Multimodal Adjuvant Therapy and Liver Transplantation for the Treatment of Hepatocellular Carcinomas Larger Than 5 Centimeters | 2002 | 4 |
| 18 | 2002 | 306 | |
| 19 | 1999 | 3 | |
| 20 | 1996 | 110 |
About Max W. Sung
Max W. Sung is a scholar working on Hepatology, Oncology, Cancer Research, Epidemiology and Pulmonary and Respiratory Medicine, having authored 82 papers that have together received 4.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (48 papers), Cancer Immunotherapy and Biomarkers (18 papers), Pancreatic and Hepatic Oncology Research (15 papers), Colorectal Cancer Treatments and Studies (9 papers), Lung Cancer Research Studies (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Hepatology (2.2k citations), Oncology (1.6k citations), Pathology and Forensic Medicine (606 citations), Cancer Research (503 citations) and Immunology (653 citations). Max W. Sung has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Myron Schwartz, Jonathan D. Schwartz, Charles M. Miller, Sukru Emre, Sasan Roayaie, Shu‐Hsia Chen, Johnny Kao, John Mandeli, Masatoshi Kudo and Ari David Baron. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer, International Journal of Radiation Oncology*Biology*Physics and Liver Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.